Our findings are a critical extension of previous pre-clinical and in vitro investigations on the interaction between Aβ, tau and αSyn, overall confirming the idea that αSyn co-pathology may actively modulate the amyloid cascade and accelerate the transition from amyloidosis to tauopathy. This evidence concerns the gene MAPT and amyloidosis.